Docosahexaenoic acid inhibits proliferation of human colon cancer cell line HT-29

doi:10.16352/j.issn.1001-6325.2024.08.1107

Abstract

Abstract: Objective To investigate the effect of docosahexaenoic acid (DHA) on human colon cancer cell line HT-29 and underlying mechanism. Methods Human colon cancer cell line HT-29 was incubated with DMSO (control), DHA (25, 50, 100 μmol/L) and 100 μmol/L DHA and/or 30 μmol/L 740Y-P. Proliferation was examined by MTT; apoptosis was detected by annexin V-FITC/PI. Western blot was used for detection of protein expression of Bcl-2, Bax apoptosis-related protein and PI3K/Akt/mTOR pathway, and RT-qPCR was used for checking mRNA expression of NLRP3/Caspase-1/IL-1β pathway. Results Compared with the control group, DHA 25, 50,and 100 μmol/L treatment of HT-29 cells resulted in decreased cell survival (P＜0.05), increased apoptosis(P＜0.05), decreased Bcl-2/Bax ratio(P＜0.05) and decreased phosphorylation of PI3K, Akt and mTOR in HT-29 cells(P＜0.05 or P＜0.01). Expressions of NLRP3, Caspase-1 and IL-1β mRNA were decreased (P＜0.05). In addition, cell viability, protein phosphorylation (p-PI3K, p-Akt, p-mTOR)and relative mRNA expression of NLRP3, Caspase 1, and IL-1β were lower in HT-29 cells which were co-incubated with DHA 100 μmol/L and 740Y-P 30 μmol/L than those in the control group (P＜0.05 or P＜0.01) and 740Y-P 30 μmol/L group (P＜0.05), while higher than that of DHA 100 μmol/L group(P＜0.05 or P＜0.01). Conclusions DHA inhibits the proliferation of human colon cancer cell line HT-29, its mechanism is potentially related to the inhibition of PI3K/Akt/mTOR and NLRP3/Caspase-1/IL-1β signaling pathways.

Key words: docosahexaenoic acid, PI3K/Akt/mTOR, NOD-like receptor pyrin domain-containing protein 3(NLRP3), colon cancer, cell proliferation

CLC Number:

R735

YAO Anjun, CHEN Lingzi, JIN Huixian. Docosahexaenoic acid inhibits proliferation of human colon cancer cell line HT-29[J]. Basic & Clinical Medicine, 2024, 44(8): 1107-1112.

References

[1] 冯思,张理,谢威,等. ω-3PUFAs在调节结直肠癌发生发展中的研究进展[J].中南大学学报(医学版),2019,44:588-595.
[2] De Freitas Rodrigues J, Philippsen HK, et al. The potential of DHA as cancer therapy strategies: a narrative review of in vitro cytotoxicity trials[J].Nutrients, 2023,15:2006. doi: 10.3390/nu15082006.
[3] Narayanankutty, Arunaksharan. PI3K/Akt/mTOR pathway as a therapeutic target for colorectal cancer: a review of preclinical and clinical evidence[J].Curr Drug Targets, 2019, 20: 1217-1226.
[4] Shao X, Lei Z, Zhou C. NLRP3 promotes colorectal cancer cell proliferation and metastasis via regulating epithelial mesenchymal transformation[J].Anti-cancer Agent Me, 2020,20:820-827.
[5] Liu Z, Li J, Shu L, et al. PI3K regulates the activation of NLRP3 inflammasome in atherosclerosis through part-dependent AKT signaling pathway[J].Exp Anim, 2021, 70: 488-497.
[6] 何可,许庆文. n-3多不饱和脂肪酸及结直肠癌模型建立的研究现状[J].海南医学,2013,24:272-274.
[7] Jayathilake AG, Luwor RB, Nurgali K, et al. Molecular mechanisms associated with the inhibitory role of long chain n-3 PUFA in colorectal cancer[J].Integr Cancer Ther, 2024, 23:15347354241243024. doi: 10.1177/15347354241243024.
[8] Leiphrakpam PD,Are C. PI3K/Akt/mTOR signaling pathway as a target for colorectal cancer treatment[J].Int J Mol Sci, 2024, 25:3178.doi: 10.3390/ijms25063178.
[9] Alzahrani AS. PI3K/Akt/mTOR inhibitors in cancer:at the bench and bedside[J].Semin Cancer Biol, 2019,59:125-132.
[10] Zhan L, Su F, Li Q, et al. Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action[J]. Front Pharmacol,2023,14:1257450.doi: 10.3389/fphar.2023.1257450.
[11] Kim N, Jeong S, Jing K, et al. Docosahexaenoic acid iInduces cell death in human non-small cell lung cancer cells by repressing mTOR via AMPK activation and PI3K/Akt inhibition[J]. Biomed Res Int,2015,2015:239764.doi:10.1155/2015/239764.
[12] Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases[J].Nat Immunol, 2021,22:550-559.
[13] Yao A,Chen J,Xu Y, et al. Endogenous n-3 polyunsaturated fatty acids prevent azoxymethane-induced colon tumorigenesis in mice fed a high-fat diet[J].J Funct Foods, 2018, 48. doi: 10.1016/j.jff.2018.07.042.
[14] Dumont A, de Rosny C, Kieu TL, et al. Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC:implication in cancer treatment[J].Cell Death Dis,2019,10:485.doi: 10.1038/s41419-019-1723-x.
[15] Qiu Y, Huang X, Huang L,et al. 5-HT(1A) receptor antagonist improves behavior performance of delirium rats through inhibiting PI3K/Akt/mTOR activation-induced NLRP3 activity[J].IUBMB Life, 2016, 68:311-319.